Cogniant is a brand that specializes in patient-led neuroscience research, offering innovative solutions for expansive digital phenotyping, clinical state predictions, and outcomes measurement. Our goal is to support researchers, clinicians, and biopharma companies throughout the entire value chain of clinical research and drug discovery for psychiatric and neurodegenerative disorders. Our clinically validated solutions are highly regarded and are being utilized by diverse patient populations worldwide.

We have formed partnerships with top academic and clinical institutions, allowing us to facilitate groundbreaking neurological research. Additionally, we work closely with leading global biopharma and biotech companies to accelerate their clinical research efforts. At Cogniant, we have created the first truly passive and patient-centric solution that captures relevant digital biomarkers across ubiquitous mobile devices.

Our solutions, such as Cogniant Connection™, Cogniant Clinical™, and Cogniant Cohort™, enable personalized treatments, objective interventions, and accelerated research within clinical and commercial environments. Whether you're a patient, physician, researcher, or a biopharma professional, Cogniant provides a clinically validated solution tailored to your specific neurological therapeutic needs. With our enriched data sets and novel data collection methods, we are committed to improving patient outcomes and driving advancements in neurological research.

Join us today and be a part of the future of neuroscience